logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Khan, Abid Javed
    Born in October 1981
    Individual (4 offsprings)
    Officer
    icon of calendar 2011-11-09 ~ now
    OF - Director → CIF 0
    Mr Abid Javed Khan
    Born in October 1981
    Individual (4 offsprings)
    Person with significant control
    icon of calendar 2016-07-21 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
Ceased 1
  • Khan, Nafeesa
    Administrator born in June 1981
    Individual
    Officer
    icon of calendar 2011-11-09 ~ 2014-04-11
    OF - Director → CIF 0
parent relation
Company in focus

ANZPHARM LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Property, Plant & Equipment
493 GBP2024-11-30
616 GBP2023-11-30
Fixed Assets
493 GBP2024-11-30
616 GBP2023-11-30
Debtors
424 GBP2024-11-30
820 GBP2023-11-30
Cash at bank and in hand
20,611 GBP2024-11-30
31,392 GBP2023-11-30
Current Assets
21,035 GBP2024-11-30
32,212 GBP2023-11-30
Net Current Assets/Liabilities
-18,040 GBP2024-11-30
11,716 GBP2023-11-30
Total Assets Less Current Liabilities
-17,547 GBP2024-11-30
12,332 GBP2023-11-30
Creditors
Non-current
-4,603 GBP2024-11-30
-7,062 GBP2023-11-30
Net Assets/Liabilities
-22,150 GBP2024-11-30
5,270 GBP2023-11-30
Equity
Called up share capital
100 GBP2024-11-30
100 GBP2023-11-30
Retained earnings (accumulated losses)
-22,250 GBP2024-11-30
5,170 GBP2023-11-30
Average Number of Employees
22023-12-01 ~ 2024-11-30
22022-12-01 ~ 2023-11-30
Property, Plant & Equipment - Gross Cost
Furniture and fittings
2,137 GBP2024-11-30
2,137 GBP2023-11-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
1,644 GBP2024-11-30
1,521 GBP2023-11-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
123 GBP2023-12-01 ~ 2024-11-30
Property, Plant & Equipment
Furniture and fittings
493 GBP2024-11-30
616 GBP2023-11-30
Other Taxation & Social Security Payable
Current
851 GBP2024-11-30
820 GBP2023-11-30
Trade Creditors/Trade Payables
Current
1 GBP2023-11-30
Other Remaining Borrowings
Current
18,077 GBP2024-11-30
Corporation Tax Payable
Current
12,616 GBP2024-11-30
19,076 GBP2023-11-30
Amounts owed to directors
Current
6,319 GBP2024-11-30
383 GBP2023-11-30
Bank Borrowings/Overdrafts
Non-current
4,603 GBP2024-11-30
7,062 GBP2023-11-30

  • ANZPHARM LIMITED
    Info
    Registered number SC410989
    icon of address13 Granville Street, Glasgow, Scotland G3 7EE
    PRIVATE LIMITED COMPANY incorporated on 2011-11-09 (14 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.